Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. März 2026 20:19 ET | Quelle: Robbins LLP

Nektar Therapeutics Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the NKTR Securities Class Action

Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
11. März 2026 19:54 ET | Quelle: Robbins LLP

Soleno Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the SLNO Class Action

Robbins LLP is Investigating Allegations that Soleno Therapeutics(SLNO) Misled Investors Regarding the Viability and Efficacy of its Phase 3 Clinical Trial
11. März 2026 19:13 ET | Quelle: Robbins LLP

Eos Energy Enterprises, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the EOSE Class Action

Robbins LLP is Investigating Allegations that Eos Energy Enterprises, Inc. (EOSE) Misled Investors Regarding its Business Prospects
11. März 2026 19:10 ET | Quelle: Robbins LLP

Driven Brands Holdings Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DRVN Class Action

Robbins LLP is Investigating Allegations that Driven Brands Holdings Inc. (DRVN) Made Material Errors in its Previously Issued Consolidated Financial State
09. März 2026 12:23 ET | Quelle: Robbins LLP

BSX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Boston Scientific Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that Boston Scientific Corporation (BSX) Misled Investors Regarding Projected Revenue
09. März 2026 12:23 ET | Quelle: Robbins LLP

AQST Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Aquestive Therapeutics, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Aquestive Therapeutics, Inc. (AQST) Misled Investors Regarding Approval of Anaphylm
05. März 2026 15:17 ET | Quelle: Robbins LLP

Robbins LLP Urges INO Stockholders Who Lost Money Investing in Inovio Pharmaceuticals, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
05. März 2026 15:12 ET | Quelle: Robbins LLP

Robbins LLP Urges Former DOOR Stockholders Who Lost Money Investing in Masonite International Corporation to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Masonite International Corporation (DOOR) Misled Investors Regarding its Acquisition by Owens Corning's Doors
05. März 2026 14:55 ET | Quelle: Robbins LLP

Robbins LLP Urges KD Stockholders Who Lost Money Investing in Kyndryl Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
05. März 2026 14:22 ET | Quelle: Robbins LLP

PSFE Class Action: Paysafe Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that Paysafe Limited (PSFE) Misled Investors Regarding its Business Prospects

Nächste Seite